Improving recovery from peripheral nerve injuries with a new injectable material
Official title: Enhancing Peripheral Nerve Repair with an Injectable Recombinant Polypeptide Scaffold
Funded at Insoma Bio, INC. · NIH-10918747 · Data updated 2026-11-12
This study is looking at a new injectable treatment called Fractomer that could help people heal better after injuries to their peripheral nerves, which can cause pain and disability.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Insoma Bio, INC. NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $296,151 |
| NIH project number | 1R41NS135845-01A1 |
| Project ID | NIH-10918747 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have suffered from peripheral nerve injuries and are seeking better treatment options.
✕Less likely to help
Patients with nerve injuries that are not suitable for surgical intervention may not benefit from this research.
What this research studies
This research investigates the use of an injectable polypeptide scaffold called Fractomer, designed to enhance recovery after peripheral nerve injuries. Peripheral nerve injuries affect millions and often lead to chronic pain and disability. The study aims to create a better healing environment by using Fractomer, which transforms from a liquid to a supportive structure that promotes nerve regeneration. By addressing the challenges of current treatment methods, this research seeks to improve patient outcomes significantly.
Why it matters
Potential benefit: If successful, this research could lead to improved recovery and reduced chronic pain for patients with peripheral nerve injuries.
How similar studies have gone: Previous research has shown promise in using biomaterials for nerve repair, suggesting that this approach could be effective.
Where this research is happening
-
Insoma Bio, INC.
Durham, United States Active
Researchers
- Principal investigator: Roberts, Stefan — Insoma Bio, INC.
- Study coordinator: Roberts, Stefan
Related research
Other NIH-funded projects on the same topics.
-
Developing a new alternative to fat transfer for repairing soft tissue
This study is working on a new, easy-to-use solution for repairing soft tissue that could help people needing reconstruction in places like the face, breasts, or arms, without the need for invasive fat grafting procedures.
-
Improving fat grafts for breast reconstruction
This study is working on a new way to make fat grafting for breast reconstruction after cancer treatment even better, so that it can be a safer and more effective option than traditional breast implants.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.